Capsule endoscopy: Do we still need it after 24 years of clinical use?

IF 5.4 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY World Journal of Gastroenterology Pub Date : 2025-02-07 DOI:10.3748/wjg.v31.i5.102692
Ahmed Tawheed, Alaa Ismail, Mohab S Amer, Osama Elnahas, Tawhid Mowafy
{"title":"Capsule endoscopy: Do we still need it after 24 years of clinical use?","authors":"Ahmed Tawheed, Alaa Ismail, Mohab S Amer, Osama Elnahas, Tawhid Mowafy","doi":"10.3748/wjg.v31.i5.102692","DOIUrl":null,"url":null,"abstract":"<p><p>In this letter, we comment on a recent article published in the <i>World Journal of Gastroenterology</i> by Xiao <i>et al</i>, where the authors aimed to use a deep learning model to automatically detect gastrointestinal lesions during capsule endoscopy (CE). CE was first presented in 2000 and was approved by the Food and Drug Administration in 2001. The indications of CE overlap with those of regular diagnostic endoscopy. However, in clinical practice, CE is usually used to detect lesions in areas inaccessible to standard endoscopies or in cases of bleeding that might be missed during conventional endoscopy. Since the emergence of CE, many physiological and technical challenges have been faced and addressed. In this letter, we summarize the current challenges and briefly mention the proposed methods to overcome these challenges to answer a central question: Do we still need CE?</p>","PeriodicalId":23778,"journal":{"name":"World Journal of Gastroenterology","volume":"31 5","pages":"102692"},"PeriodicalIF":5.4000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718605/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3748/wjg.v31.i5.102692","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In this letter, we comment on a recent article published in the World Journal of Gastroenterology by Xiao et al, where the authors aimed to use a deep learning model to automatically detect gastrointestinal lesions during capsule endoscopy (CE). CE was first presented in 2000 and was approved by the Food and Drug Administration in 2001. The indications of CE overlap with those of regular diagnostic endoscopy. However, in clinical practice, CE is usually used to detect lesions in areas inaccessible to standard endoscopies or in cases of bleeding that might be missed during conventional endoscopy. Since the emergence of CE, many physiological and technical challenges have been faced and addressed. In this letter, we summarize the current challenges and briefly mention the proposed methods to overcome these challenges to answer a central question: Do we still need CE?

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胶囊内窥镜:临床使用24年后,我们还需要它吗?
在这封信中,我们评论了Xiao等人最近发表在《世界胃肠病学杂志》上的一篇文章,该文章的作者旨在使用深度学习模型在胶囊内窥镜检查(CE)过程中自动检测胃肠道病变。CE于2000年首次提出,并于2001年获得美国食品和药物管理局的批准。CE的适应症与常规内镜诊断的适应症重叠。然而,在临床实践中,CE通常用于检测标准内窥镜无法检测的区域的病变,或者用于检测传统内窥镜可能遗漏的出血病例。自CE出现以来,许多生理和技术挑战已经面临和解决。在这封信中,我们总结了当前的挑战,并简要介绍了克服这些挑战的建议方法,以回答一个核心问题:我们还需要行政长官吗?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
World Journal of Gastroenterology
World Journal of Gastroenterology 医学-胃肠肝病学
CiteScore
7.80
自引率
4.70%
发文量
464
审稿时长
2.4 months
期刊介绍: The primary aims of the WJG are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in gastroenterology and hepatology.
期刊最新文献
Influence of blood transfusion on outcomes in patients with gastric cancer. Correction to "Metadherin promotes stem cell phenotypes and correlated with immune infiltration in hepatocellular carcinoma". Distribution and prognostic value of macrophages in colorectal cancer and adjacent mucosa in patient stages I-III vs IV. Gut bacterial and fungal signatures in relation to human leukocyte antigen-DQ2/DQ8 in children with celiac disease and siblings. Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1